Portfolio Building Block World Pharma and Biotech Index ETF
Ticker: PBPH
About PBPH
The Portfolio Building Block World Pharma and Biotech Index ETF seeks to provide investors with targeted exposure to the global pharmaceutical and biotechnology industries, two of the most dynamic and innovation-driven sectors in healthcare. The fund seeks to replicate the performance of the BITA Global Pharma and Biotech Select Index, which tracks companies in developed markets that derive a significant portion of their revenue from the discovery, development, and commercialization of human therapeutics.
About the Underlying Index
The BITA Global Pharma and Biotech Select Index is a rules-based equity index designed to measure the performance of companies in developed markets that play a leading role in the pharmaceutical and biotechnology sectors. The index captures firms that derive a significant share of their revenues from the research, development, and commercialization of human therapeutics, including both biotechnology-driven innovations and traditional pharmaceutical products.
Fund Details
| Fund Inception | 11/24/2025 |
| Fund Name | Portfolio Building Block World Pharma and Biotech Index ETF |
| Ticker | PBPH |
| Primary Exchange | Nasdaq |
| CUSIP | 88635A204 |
| Gross Expense Ratio | 0.13% |
| 30 Day SEC Yield* As of 12/31/2025 | 3.52 |
*The subsidized SEC yield is calculated with a standardized formula mandated by the SEC. The formula is based on maximum offering price per share and includes the effect of any fee waivers. Without waivers, yields would be reduced. This is also referred to as the “standardized yield,” “30-Day Yield” and “Current Yield”.
Fund Data & Pricing
| Net Assets | $31.36m | ||
| NAV | $25.92 | ||
| Shares Outstanding | "1 | 210 | 000" |
| Premium/Discount Percentage | N/A | ||
| Closing Price | N/A | ||
| Median 30 Day Spread* | N/A |
As of: 01/28/2026
*30-Day Median Spread is a calculation of Fund’s median bid-ask spread, expressed as a percentage rounded to the nearest hundredth, computed by: identifying the Fund’s national best bid and national best offer as of the end of each 10 second interval during each trading day of the last 30 calendar days; dividing the difference between each such bid and offer by the midpoint of the national best bid and national best offer; and identifying the median of those values.
Performance
Inception Date: 11/24/2025
As of: 01/30/2026
| Fund Name | Fund Ticker | 1 Month | 3 Month | 6 Month | YTD | 1 Year | 3 Year | 5 Year | 10 Year | Since Inception (Cumulative) | Since Inception (Annualized) | Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Portfolio Building Block World Pharma and Biotech Index ETF | PBPH MKT | 0.46 | - | - | - | - | - | - | - | - | - | 12/31/2025 |
| Portfolio Building Block World Pharma and Biotech Index ETF | PBPH NAV | 0.56 | - | - | - | - | - | - | - | 0.88 | - | 12/31/2025 |
As of: 01/30/2026
| Fund Name | Fund Ticker | 1 Month | 3 Month | 6 Month | YTD | 1 Year | 3 Year | 5 Year | 10 Year | Since Inception (Cumulative) | Since Inception (Annualized) | Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Portfolio Building Block World Pharma and Biotech Index ETF | PBPH MKT | 0.46 | - | - | - | - | - | - | - | - | - | 12/31/2025 |
| Portfolio Building Block World Pharma and Biotech Index ETF | PBPH NAV | 0.56 | - | - | - | - | - | - | - | 0.88 | - | 12/31/2025 |
The performance data quoted represents past performance and is no guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted. For the most recent month-end performance, please call (877) 955-2433.
Short term performance, in particular, is not a good indication of the Fund’s future performance, and an investment should not be made based solely on returns. Returns beyond 1 year are annualized. A Fund’s NAV is the sum of all its assets less any liabilities, divided by the number of shares outstanding. The market price is the most recent price at which the fund was traded. The fund intends to pay out dividends and interest income, if any, weekly. There is no guarantee these distributions will be made.
Top 10 Holdings
As of: 01/29/2026
Holdings are subject to change without notice.
| Date | Account | StockTicker | CUSIP ▲ | Name ▲ | Shares ▲ | Price ▲ | Market Value ▲ | Weightings ▲ | NetAssets | SharesOutstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| 01/29/2026 | PBPH | LLY | 532457108 | ELI LILLY & CO | 4465.0 | 1023.80 | 4571267.00 | 14.5756% | ||
| 01/29/2026 | PBPH | JNJ | 478160104 | JOHNSON & JOHNSON | 12586.0 | 227.72 | 2866083.92 | 9.1386% | ||
| 01/29/2026 | PBPH | ABBV | 00287Y109 | ABBVIE INC | 9209.0 | 218.67 | 2013732.03 | 6.4208% | ||
| 01/29/2026 | PBPH | ROG | 7110388 | ROCHE HOLDING AG-GENUSSCHEIN | 3644.0 | 338.30 | 1602554.70 | 5.1098% | ||
| 01/29/2026 | PBPH | NOVN | 7103065 | NOVARTIS AG-REG | 10528.0 | 114.20 | 1562947.81 | 4.9835% | ||
| 01/29/2026 | PBPH | AZN | 0989529 | ASTRAZENECA PLC | 7744.0 | 135.08 | 1442562.15 | 4.5997% | ||
| 01/29/2026 | PBPH | MRK | 58933Y105 | MERCK & CO. INC. | 13432.0 | 106.90 | 1435880.80 | 4.5784% | ||
| 01/29/2026 | PBPH | NOVOB | BP6KMJ1 | NOVO NORDISK A/S-B | 23354.0 | 381.45 | 1425022.12 | 4.5437% | ||
| 01/29/2026 | PBPH | AMGN | 031162100 | AMGEN INC | 3975.0 | 342.22 | 1360324.50 | 4.3374% | ||
| 01/29/2026 | PBPH | GILD | 375558103 | GILEAD SCIENCES INC | 9076.0 | 139.72 | 1268098.72 | 4.0434% |
Fund Documents
Purchase
The Fund (PBPH) is available through various channels including via phone (877) 955-2433, broker-dealers, investment advisers, and other financial services firms, including:
